Universal “Circulating Tumor Cell Market” to Rise Ecstatically At a 13.8% CAGR | MRFR Reveals Industry Foresights Up To 2023

“Circulating Tumor Cell Market”
Market Research Future (MRFR) announces the publication of its research report – Global Circulating Tumor Cell Market and Provide detail analysis of Global Circulating Tumor Cell Market with respect to region and competitive analysis and Detail analysis of the parent market with different drivers and restraints affecting the growth of the circulating tumor cell.

This MRFR report offers a full-fledged analysis of the global market for circulating tumor cells. It also discuses the market opportunities for biomarkers active in the particular class as well as identifies the existing challenges. The primary objective of the report is to provide a five-year (2018-2023) revenue assessment of the global CTC market. MRFR’s report holds a fair perspective towards the CTC market and explores the application scope of the existing CTC technologies in clinical, research and drug development activities. The research document also profiled CTC technologies that are currently available, which include CTC Enrichment, CTC Detection and Combined Enrichment and Separation of CTC (CTC analysis). Revenue analysis on the basis of major end users of CTC technology covers hospital & clinics, research & academic institutes and diagnostic centers. The report undertakes a market study on a global level, which covers South America, North America, Asia Pacific (APAC), the Middle East & Africa (MEA) and Europe.

Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1362

Key Players for Global Circulating Tumor Cell Market

Key players in this market are ApoCell, Inc. (US), Biocep Ltd. (Israel), Fluxion Biosciences, Inc. (US), Biocept, Inc. (US), Biofluidica Microtechnologies LLC (US), Creatv Microtech, Inc. (US), Celltraffix Inc. (US), Clearbridge Biomedics (Singapore), Janssen Diagnostics LLC (US), Cynvenio Biosystems, Inc. (US), STEMCELL Technologies, Inc. (Canada), Epic Biosciences Inc. (US), Ikonisys, Inc. (US), IVDiagnostics, Inc. (US), ScreenCell (France), RARECELLS SAS (Italy), Epic Sciences (US), QIAGEN Hannover GmbH (Germany), Celula (US), Advanced Cell Diagnostics (US) and  AdnaGen (Germany)

In 2017, the global market size of circulating tumor cell (CTC) reached a valuation of USD 9,393.1 Mn. The market is projected to surpass a valuation of USD 28,300 Mn by the end of 2023, reflecting a healthy growth rate. The prevalence rate of CTC has gone up in recent years. The mechanism of CTC is responsible for a vast majority of deaths caused by cancer. Significant progress has been made in developing effective CTC diagnostics and treatment, though, survival rates remain moderate. Circulating tumor cells can be associated with different types of cancer prognosis including breast cancer, prostate cancer, and gastric cancer among others. Healthcare companies continue to focus on developing solutions that enable accurate and quick detection of CTC. The diagnosis and analysis of CTCs can help in early cancer detection and determine appropriate treatments tailored for specific cancer types.

Segments for Global Circulating Tumor Cell Market

MRFR’s report offers a detailed segmental analysis of the market based on application, technology, and end-user.

By application, the market has been segmented into clinical, research, drug development, and others. The clinical segment is further sub-segmented into clinical prognostic, diagnosis and management of tumor malignancies, and drug decision. It currently holds the most significant share of the global market and is set to expand from USD 5,920.9 Mn in 2017 to USD 18,225.8 Mn by 2023.

By technology, the market is segmented into CTC enrichment, CTC detection, and CTC analysis. Among these, the CTC enrichment segment commands the largest market share which accounts for 58.5% share. It is likely to retain its prominence during the assessment period. The growth is attributable to its ability to reduce the time needed to isolate rare Circulating Tumor Cells (CTCs) and improve selectivity, sensitivity, etc.

By end-user, the market is segmented into hospitals and clinics, research and academic institutes, diagnostic centers, and others. Among these, the hospitals and clinics segment is likely to control a dominant share of the market throughout the forecast period. The segment is projected to register a CAGR of 20.92% over 2023.

Regional Analysis for Global Circulating Tumor Cell Market

On regional basis, North America has a leading market for circulating tumor cells. According to National Cancer Institute, in 2014 14 million people in North America were suffering from cancer and number of these patients are increasing continuously. It is the major reason for the development of this market in North America. Europe has the second largest circulating tumor cells market which is followed by Asia Pacific. Asia Pacific is the fastest growing region for circulating tumor cells due to huge population base, rapid development in healthcare sector, infrastructure development and many more factors. Middle East and Africa has the least market for circulating tumor cells.

The report for global circulating tumor cell market of Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market’s segments and regions.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

TOC Continued…

Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/1362

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/circulating-tumor-cell-market-1362